Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia

Bone Marrow Transplantation

Volumn 17, Issue 1, 1996, Pages 75-80

  Rozman, C ^a   Carreras, E ^a   Qian, C ^b   Gale, R P ^c   Bortin, M M ^b   Rowlings, P A ^b   Ash, R C ^b   Champlin, R E ^d   Henslee Downey, P J ^e   Herzig, R H ^f   Hinterberger, W ^g   Klein, J P ^b   Prentice, H G ^h   Reiffers, J ⁱ   Zwaan, F E ^j   Horowitz, M M ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c Salick Health Care Inc   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSITY OF SOUTH CAROLINA   (United States)

^f JEWISH HOSPITAL   (United States)

^g DANUBE HOSPITAL   (Austria)

^h ROYAL FREE HOSPITAL   (United Kingdom)

ⁱ BORDEAUX UNIVERSITY HOSPITAL   (France)

^j KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

more..

Author keywords

BMT; Risk factors; Veno occlusive disease

Indexed keywords

ACICLOVIR; AMPHOTERICIN; ANTIFUNGAL AGENT; BUSULFAN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN; KETOCONAZOLE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; ASCITES; CHILD; CLINICAL FEATURE; FEMALE; HEPATOMEGALY; HLA MATCHING; HUMAN; JAUNDICE; LEUKEMIA; LIVER DISEASE; LIVER VEIN OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; MYCOSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SIBLING; VIROLOGY; WEIGHT GAIN; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HEPATIC VENO-OCCLUSIVE DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; INFANT; LEUKEMIA; MALE; MIDDLE AGED; RISK FACTORS;

EID: 13344250481     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Shulman HM, Hinterberger W. Hepatic veno-occlusive disease - liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 197-214.
2. Carreras E, Graneña A, Rozman C. Hepatic veno-occlusive disease after bone marrow transplant. Blood Rev 1993; 7: 43-51.
3. McDonald GB, Sharma P, Matthews DE et al. Veno-occlusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984; 4: 116-122.
4. Carreras E. Graneña A, Navasa M et al. On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive diseae. Ann Hematol 1993; 66: 77-80.
5. McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255-267.
6. Carreras E, Granena A, Navasa M et al. Transjugular liver biopsy in bone marrow transplantation. Bone Marrow Transplant 1993; 11: 21-26.
7. Shulman HM, McDonald GB, Matthews D et al. An analysis of hepatic veno-ocdusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterology 1980; 79: 1178-1191.
8. Cox DR. Regression models and life tables. JR Stat Soc B 1972; 34: 187-220.
9. Rimm AA, Barr JT, Horowitz MM, Bortin MM. Use of a clinical data registry to evaluate medical technologies, Int J Tech Assess Health Care 1991; 7: 182-193.
10. Horowitz M, Bortin M. The role of registries in evaluating the results of bone marrow transplantation. In: Treleavan J, Barret J (eds). Bone Marrow Transplantation in Practice. Churchill-Livingstone: New York. 1992, pp 367-377.
11. Méresse V. Hartmann O. Vassal G et al. Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children. Bone Marrow Transplant 1992; 10: 135-141.
12. Okaynak MF, Weinberg K, Kohn D et al. Hepatic venoocclusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome. Bone Marrow Transplant 1991; 7: 467-474.
13. Atkinson K, Biggs J, Noble G et al. Preparative regimens for marrow transplantation containing busulfan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis. Bone Marrow Transplant 1987; 2: 385-394.
14. Beelen DW, Quabeck K, Graeven U et al. Acute toxicity and first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia. Blood 1989; 74: 1507-1516.
15. Brodsky R, Topolsky D, Crilley P et al. Frequency of venoocclusive disease of the liver in bone marrow transplantation with a modified busulfan/cyclophosphamide preparative regimen. Am J Clin Oncol 1990; 13: 221-225.
16. Morgan M, Dodds A, Atkinson K et al. The toxicity of busulfan and cyclophosphamide as the preparative regimen for bone marrow transplantation. Br J Haematol 1991; 77: 529-534.
17. Vaughan WP, Dennison JD, Reed EC et al. Improved results of allogeneic bone marrow transplantation for advanced hematologic malignancy using busulfan, cyclophosphamide and, etoposide as cytoreductive and immunosuppressive therapy. Bone Marrow Transplant 1991; 8: 4489-595.
18. Van der Jagt RHC, Appelbaum FR. Petersen FB et al. Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy. Bone Marrow Transplant 1991; 8: 211-215.
19. 2, Blood 1991; 78: 838-843.
20. Ganem G, Saint-Marc Girardin MF, Kuentz M et al. Venocclusive disease of the liver after allogeneic bone marrow transplantation in man. Int J Radiat Oncol Biol Phys 1988; 14: 879-884.
21. Brugieres L, Hartmann O, Benhamou E et al. Veno-occlusive disease of the liver following high-dose chemotherapy and autologous bone marrow transplantation in children with solid tumors: incidence, clinical course and outcome. Bone Marrow Transplant 1988; 3: 53-58.
22. Sullivan KM, Kenneth J, Jocom J et al. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in ne marrow transplantation. New Engl J Med 1990; 323: 705-712.
23. Berk PD, Popper H, Krueger GRF et ai. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation. Possible association with graft-versus-host disease. Ann Intern Med 1979; 90: 158-164.
24. Dulley FL, Kanfer EJ, Appelbaum FR et al. Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation. Transplantation 1987; 43: 870-873.
25. Soiffer RJ, Dear K. Rabinowe SN et al. Hepatic dysfunction following T cell-depleted allogeneic bone marrow transplantation. Transplantation 1991; 52: 1014-1019.
26. Nash R, Pepe M, Storb R et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992; 80: 1838-1845.